Registry of Patients Treated With Systemic Mold-Active Triazoles

Completed

Conditions studied: Invasive Fungal Infection

In brief

The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).

Key facts

Study ID

NCT03066011

Run by

Astellas Pharma Global Development, Inc.

People needed

2015

Starts

2017-03-16

Expected to finish

2020-04-24

Last updated by the study team

2024-10-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients taking one of the following target drugs at the time of enrollment: isavuconazonium sulfate (ISAV), voriconazole (VORI), posaconazole (POSA).

You may not qualify if…

• Currently enrolled in any clinical trial with an investigational antifungal agent. Individuals who subsequently enroll in an investigational antifungal study will be discontinued and data collected up to the time of investigational product will be evaluable.
• Patients who died before entering the study.
• Patients who previously participated in this registry.

Where it is running

• St. Joseph's Hospital — Phoenix, Arizona, United States
• Mayo Clinic — Phoenix, Arizona, United States
• University of Arizona — Tucson, Arizona, United States
• University of California — Davis, California, United States
• David Geffen School of Medicine — Los Angeles, California, United States
• Stanford Health Care — Palo Alto, California, United States
• Olive View UCLA Medical Center — Sylmar, California, United States
• LA BioMed — Torrance, California, United States
• University of Colorado — Aurora, Colorado, United States
• Yale School of Medicine — New Haven, Connecticut, United States
• Emory University — Atlanta, Georgia, United States
• Augusta University — Augusta, Georgia, United States
• Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
• Northwestern University — Chicago, Illinois, United States
• University of Illinois at Chicago — Chicago, Illinois, United States
• University of Chicago — Chicago, Illinois, United States
• Loyola University — Chicago, Illinois, United States
• Springfield Clinic — Springfield, Illinois, United States
• Indiana University Health — Indianapolis, Indiana, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• University of Kentucky — Lexington, Kentucky, United States
• Norton Cancer Institute — Louisville, Kentucky, United States
• Tulane Medical Center — New Orleans, Louisiana, United States
• Ochsner Clinic Foundation — New Orleans, Louisiana, United States
• University of Alabama - Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.